Moderna Competitors and Similar CompaniesClear all

Moderna's competitors and similar companies include CureVac, Regulus Therapeutics, Celyad and Sarepta Therapeutics.
Moderna
Moderna
Moderna is a biotechnology company that develops therapeutics and vaccines.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
Founding Date
Founding Date
2010
Founding Date
2000
Founding Date
2007
Founding Date
2007
Founding Date
1980
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Norwood, US
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Locations
San Diego, US HQ
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Locations
Cambridge, US HQ
Dublin, IE
Zug, CH
Providence, US
Employees
Employees
3,90044% increase
Employees
90440% increase
Employees
2462% decrease
Employees
35
Employees
8403% decrease
Valuation ($)
Valuation ($)
35.9 b
Valuation ($)
765.8 m
Valuation ($)
29.9 m
Valuation ($)
N/A
Valuation ($)
12.9 b
Twitter followers
Twitter followers
151.2 k
Twitter followers
12
Twitter followers
790
Twitter followers
2.4 k
Twitter followers
5 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
17
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
13
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
39.6
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
40.6
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
69.23%
Employee Rating
Employee Rating
3.7
Employee Rating
3.2
Employee Rating
2.8
Employee Rating
3.5
Employee Rating
4.1

Financial

Revenue (est.)
Revenue (est.)
$6.8b (FY, 2023)
Revenue (est.)
€67.4m (FY, 2022)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$933m (FY, 2022)
Cost of goods
Cost of goods
$4.7b (FY, 2023)
Cost of goods
€93.2m (FY, 2022)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$2.2b (FY, 2023)
Gross profit
€12.1m (FY, 2022)
Gross profit
N/A
Gross profit
€24.1m (FY, 2022)
Gross profit
N/A
Net income
Net income
($4.7b) (FY, 2023)
Net income
(€249m) (FY, 2022)
Net income
($28.3m) (FY, 2022)
Net income
(€40.9m) (FY, 2022)
Net income
($703.5m) (FY, 2022)

Operating

Patent Applications
Patent Applications
430 (FY, 2021)
Patent Applications
500 (Mar, 2020)
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patents Issued
Patents Issued
270 (FY, 2020)
Patents Issued
233 (May, 2020)
Patents Issued
300 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
$ 1.8b
Total funding raised
$ 1.1b
Total funding raised
$ 10m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

CureVac
HQ
Tübingen, DE
Employees
904↑ 40% increase

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.

View company
Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company
Celyad
HQ
Mont-Saint-Guibert, BE
Employees
35

Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.

View company
Sarepta Therapeutics
HQ
Cambridge, US
Employees
840↓ 3% decrease

Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.

View company